• ChemFaces is a professional high-purity natural products manufacturer.
  • Product Intended Use
  • 1. Reference standards
  • 2. Pharmacological research
  • 3. Inhibitors
  • Home
  • Natural Products
  • Bioactive
  • Screening Libraries
  • Hot Products
  • Plant Catalog
  • Customer Support
  • Product Use Citation
  • About Us
  • Contact Us
  • Bioactive Products
    Anti-platelet-aggregation Compound Library
    A unique collection of 51 Anti-platelet aggregation natural compounds
    Catalog No: B24 Anti-platelet-aggregation Compound Library
    Screening Details
    Size: 1mg/well * 51 Compounds
    2mg/well * 51 Compounds
    Catalog No. Information
    CFN99410 Chrysophanol 8-O-glucoside

    1. Chrysophanol 8-O-beta-D-glucoside has cytotoxic activity.
    2. Chrysophanol 8-O-beta-D-glucoside is potential antioxidant.
    3. Chrysophanol 8-O-beta-D-glucoside shows a strong inhibitory effect on HBV DNA release.
    CFN99433 Pomolic acid

    1. Pomolic acid inhibits DNA polymerase.
    2. Pomolic acid has anticancer property of pomolic acid-induced AMP-activated protein kinase activation in MCF7 human breast cancer cells.
    3. Pomolic acid shows anti-HIV effect, by inhibiting HIV-1 replication in acutely infected H9 cells with an EC50 value of 1.7 microg/mL, and inhibiting H9 cell growth with an IC50 value of 21.8 microg/mL [therapeutic index (T. I.) 12.8].
    CFN99161 Salvianolic acid A

    1. Salvianolic acid A has anti-oxidative capability.
    2. Salvianolic acid A positively regulates PTEN protein level and inhibits growth of A549 lung cancer cells.
    3. Salvianolic acid A inhibits proliferation, causes cell cycle arrest at the S phase, and induces apoptosis dose dependently to the two kinds of cancer cells.
    4. Salvianolic acid A has inhibitory effect on Cu2+ mediated human LDL oxidation through chelating Cu2+ and scavenging free radicals.
    5. Salvianolic acid A could protect hepatic lipid peroxidation, and had marked effects against liver injur y and fibrosis in carbon tetrachloride induced fibrotic rats.
    6. Salvianolic acid A has inhibitory effect on Cu2+ mediated human LDL oxidation through chelating Cu2+ and scavenging free radicals.
    7. Salvianolic acid A can reverse paclitaxel resistance through suppressing transgelin 2 expression by mechanisms involving attenuation of PI3 K/Akt pathway activation and ABC transporter up-regulation.
    CFN99532 Anemarsaponin B

    1. Anemarsaponin B can inhibit PAF-induced rabbitplatelet aggregation in vitro.
    CFN99491 Hispidulin

    1. Hispidulin has antineoplastic activity.
    2. Hispidulin has antioxidant properties and effect on mitochondrial energy metabolism.
    3. Hispidulin has a potential treatment for hyper-dopaminergic disorders.
    4. Hispidulin has considerable antiepileptic, neuroprotective, and antiinflammatory effects on kainic acid-induced seizures in rats.
    5. Hispidulin exerts anti-osteoporotic and bone resorption attenuating effects via activating the AMPK signaling pathway.